(2004). However, the distinctive mushroom-like structure, commonly described in Pseudomonas aeruginosa biofilms (Davies et al., 1998), was never observed. In contrast, bacterial aggregates were found either adherent to the ETT lumen or within the overlying secretions through SEM (Fig. 7). We found that systemic treatment with linezolid decreases bacterial survival ratio within ETT by direct quantitative assessment through CLSM. However, bacterial eradication

was not achieved, selleck products indicating insufficient bactericidal effect inside the biofilm likely due to both the intrinsic resistance of biofilms to antimicrobials (Mah & O’Toole, 2001; Stewart & Costerton, 2001) and the impaired distribution of antimicrobials inside the ETT (Fernández-Barat et al., 2011). To the best of our knowledge, this is the first report demonstrating bacterial aggregates, within the ETT, adherent and non-attached at the ETT surface, as clearly depicted in Fig. 7. It could be argued that the structures seen in the ETTs of our animal model were bacterial aggregates, not producing biofilm, and totally embedded within respiratory mucus. Indeed, in this model, it is challenging to distinguish Cobimetinib between respiratory mucus and MRSA biofilm, because MRSA biomatrix mainly consists

of N-acetyl glucosamine (O’Gara, 2007) that is virtually indistinguishable from human mucus (Voynow & Rubin, 2009). However, the results on biofilm-forming capability between MRSA isolated from within the tube and MRSA to originally challenge the animals clearly imply that MRSA within the ETT was actively very forming biofilm (Fig. 2). Furthermore, bacterial aggregates in our samples

undoubtedly meet all the criteria established to define biofilm clusters (Parsek & Singh, 2003). The use of CLSM to qualitatively assess bacterial biofilm within ETT has substantially increased over the years (Perkins et al., 2004). In particular, CLSM has been commonly applied to assess efficacy of silver-coated ETT (Olson et al., 2002; Berra et al., 2008; Kollef et al., 2008; Rello et al., 2010), or novel devices designed to mechanically disrupt ETT biofilm (Berra et al., 2006, 2012). Nevertheless, quantitative CLSM assessment of ETT biofilm viability has never been reported, neither were used enhanced methods to clearly distinguish bacteria within the biofilm matrix inside ETT, which is important in terms of reproducibility. In our studies, an additional advantage of the use of CLSM was the capability to measure the total amount of bacteria within the biofilm irrespective of whether they were alive or dead. These assessments are clearly impossible to obtain through standard bacterial culture and relate to both antimicrobial efficacy and length of mechanical ventilation. Interestingly, we found more biofilm in ETTs retrieved from treated animals.